BACKGROUND
Treatments of recurrent cases of colorectal carcinoma are often difficult, but recent studies report that continuous infusion of high doses of 5-fluorouracil(5-FU) and combined 5-FU plus leucovor in achieve the remarkable response.
It is important to know the chemosensitivity for 5-FU in each case , but it is difficult to collect the materials from the recurrent cases for testing chemosensitivity, and also the successful rates themselves of chemosensitivity test have not been achieved.
The purpose of this study is to use the results of histopathological effects of preoperative chemotherapy using UFT as a chemosensitivity test for 5-FU at the time of the recurrence of colorectal carcinoma. 
MATERIALS AND METHODS

Patients
RESULTS
Fifty-five patients of colorectal carcinoma were given UFT preoperatively, and the total doses were 4.2-17.4g (average 7.94±2.24) .
Although yet undocumented, in 14 of 55 cases (25.5%: 2 cases were grade 3 and 12 cases were grade 2), it was discovered that the patients with a grade 2 or higher were sensitive to 5-FU. (Table 2 UFT as an adjuvant chemotherapy.
In the adjuvant chemotherapy group, recurrences were seen in one of 4 in the sensitive group (25%) and in 4 of 28 in the non-sensitive group (14.3%).
In the course of study, relationships between chemosensitivity and histopathological effects were examined retrospectively, and a new protocol of prospective study has been created.
In the new protocol, sensitive cases are divided into two groups with or without adjuvant chemotherapy, and non-sensitive cases are also divided into two groups. 
